Skip to main content
Fig. 3 | Breast Cancer Research

Fig. 3

From: Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models

Fig. 3

IHC analysis of human CD45+, CD20+, CD68+, CD56+, CD4+, and CD8+ cells and cells present in MC1 tumor xenografts. Representative images (from a total of 8–10 processed samples in each group) of IHC performed in preparations of MC1 tumor samples grown in either humanized or nonhumanized nonobese diabetic/severe combined immunodeficiency IL2Rγnull (NSG) mice corresponding to samples shown in Fig. 2a or c, respectively. 4× (inset) and 20× magnifications are shown; counterstain, hematoxylin.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us